DCS

DCS, as an independent mid-sized company, focuses on the distribution and development of innovative products for human medical diagnostics. The emphasis is on biochemical and immunoassay reagents and testing systems. In addition to our own product lines, we also offer selected products from international partners. The portfolio includes over 1,800 products, including primary antibodies, high-sensitivity detection systems, chromogens, and other reagents, as well as high-performance immunostainers. DCS has been ISO 13485 certified since 2000 and provides in vitro diagnostics with IVD/CE marking. We serve universities, other research institutions, and hospitals as well as private laboratories in Germany and abroad. Key areas of work include oncology, cytopathology, and other application fields of morphological-immunohistochemical methods. Novel primary antibodies for immunohistochemistry enable clearer diagnostic statements, particularly in pathology.